Commonwealth Equity Services LLC Has $99,000 Position in Monogram Orthopaedics, Inc. (NASDAQ:MGRM)

Commonwealth Equity Services LLC lifted its holdings in shares of Monogram Orthopaedics, Inc. (NASDAQ:MGRM) by 21.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 41,628 shares of the company’s stock after buying an additional 7,366 shares during the period. Commonwealth Equity Services LLC’s holdings in Monogram Orthopaedics were worth $99,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of MGRM. Barclays PLC bought a new position in Monogram Orthopaedics in the third quarter valued at approximately $29,000. State Street Corp acquired a new position in Monogram Orthopaedics during the third quarter worth $62,000. Geode Capital Management LLC grew its position in shares of Monogram Orthopaedics by 1,267.4% in the 3rd quarter. Geode Capital Management LLC now owns 210,144 shares of the company’s stock valued at $557,000 after acquiring an additional 194,776 shares during the period. Finally, Fiduciary Family Office LLC acquired a new position in shares of Monogram Orthopaedics during the 4th quarter worth about $70,000. Institutional investors and hedge funds own 0.45% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on MGRM shares. Roth Capital set a $5.40 target price on shares of Monogram Orthopaedics in a research note on Tuesday, March 18th. Roth Mkm boosted their target price on Monogram Orthopaedics from $4.00 to $5.40 and gave the stock a “buy” rating in a report on Tuesday, March 18th.

Monogram Orthopaedics Stock Performance

Shares of MGRM stock opened at $2.52 on Friday. The company has a 50-day simple moving average of $2.62 and a 200 day simple moving average of $2.49. The company has a market capitalization of $88.93 million, a price-to-earnings ratio of -5.36 and a beta of 0.77. Monogram Orthopaedics, Inc. has a 52 week low of $1.82 and a 52 week high of $4.21.

Monogram Orthopaedics (NASDAQ:MGRM) last released its quarterly earnings results on Wednesday, March 12th. The company reported ($0.08) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.03. Sell-side analysts forecast that Monogram Orthopaedics, Inc. will post -0.49 EPS for the current year.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.